WaveMan · Form 4
Powl Brian T. insider trades
> Search tickers & screens ⌘K
LIVE

Powl Brian T. insider trades

Powl Brian T. has filed 15 Form 4s with the SEC that we hold, for Kura Oncology, Inc. (KURA) (Chief Commercial Officer) and Fate Therapeutics INC (FATE) (Chief Commercial Officer). Across all of them we count 0 purchases worth $0 and 12 sales worth $774.2K reported on Form 4. In the last 12 months: 0 purchases ($0) and 9 sales ($663.4K). The largest single trade was a sale of 15,430 shares of Kura Oncology, Inc. worth $165.9K, dated 2026-09-29. Of 4 sales filed since we began reading the 10b5-1 checkbox, 1 (25%) was marked as made under a 10b5-1 trading plan. The first filing on our record is dated 2022-06-29 and the latest 2026-09-29.

Kura Oncology, Inc. (KURA)

Chief Commercial Officer · 12 filings · 11 purchases and sales
Trade dateCodeSharesValue as filedFiled
2025-01-28S, sale reported on Form 41,583$12.5K2025-01-28
2025-09-29S, sale reported on Form 48,891$79.5K2025-09-29
2025-11-14S, sale reported on Form 48,887$99.4K2025-11-14
2026-01-27S, sale reported on Form 41,572$13.3K2026-01-27
2026-01-27S, sale reported on Form 44,842$41.0K2026-01-27
2026-05-19S, sale reported on Form 4339$3.1K2026-05-20
2026-05-21S, sale reported on Form 410,000$110.0K2026-05-22
2026-08-21S, sale reported on Form 44,345$51.7K2026-08-24
2026-09-28S, sale reported on Form 49,020$94.7K2026-09-29
2026-09-28S, sale reported on Form 48,000$84.5K2026-09-29
2026-09-29S, sale reported on Form 415,430$165.9K2026-09-29

Fate Therapeutics INC (FATE)

Chief Commercial Officer · 3 filings · 1 purchase or sale
Trade dateCodeSharesValue as filedFiled
2023-07-05S, sale reported on Form 43,854$18.8K2023-07-06
Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1934232) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-12 · For informational purposes only, not investment advice.
Privacy · Terms